A direct oral anticoagulant (DOAC) that prevents blood clots by directly inhibiting factor Xa in the clotting cascade. Unlike warfarin, it doesn't require routine blood monitoring and has fewer drug interactions.
A modern pharmaceutical name combining 'riva-' (possibly from 'rival' to warfarin) + 'roxaban', where '-xaban' is the standard suffix for direct factor Xa inhibitors. Developed in the 2000s as part of the new generation of oral anticoagulants.
Rivaroxaban represents a revolution in blood thinning - it's like having a precision sniper rifle instead of a shotgun! While warfarin affects multiple clotting factors and requires constant monitoring, rivaroxaban targets just one specific step in the clotting process with predictable effects.
Complete word intelligence in one call. Free tier — 50 lookups/day.